Early development of coronary artery aneurysms after implantation of biolimus-eluting stent with biodegradable polymer

Int J Cardiol. 2015 Apr 1:184:487-488. doi: 10.1016/j.ijcard.2015.02.082. Epub 2015 Feb 25.

Authors

Alexander Goldberg¹, Alexander Zdorovyak², Inna Rosenfeld³, Irena Nordkin³

Affiliations

¹ Interventional Cardiology, Ziv Medical Center, Zfat, Israel; Faculty of Medicine in Galilee, Bar-Ilan University, Zfat, Israel. Electronic address: Alex.g@ziv.health.gov.il.
² Cardiology Department, Rambam Medical Center, Haifa, Israel.
³ Cardiology Department, Ziv Medical Center, Zfat, Israel.

PMID: 25756573
DOI: 10.1016/j.ijcard.2015.02.082

No abstract available

Keywords: Coronary aneurysm; Coronary angioplasty; Drug-eluting stents.

Publication types

Case Reports
Letter

MeSH terms

Absorbable Implants / adverse effects
Angina Pectoris / diagnosis
Angina Pectoris / etiology*
Angina Pectoris / physiopathology
Angioplasty, Balloon, Coronary* / adverse effects
Angioplasty, Balloon, Coronary* / instrumentation
Angioplasty, Balloon, Coronary* / methods
Antibiotics, Antineoplastic / pharmacology
Coronary Aneurysm* / diagnosis
Coronary Aneurysm* / etiology
Coronary Aneurysm* / physiopathology
Coronary Angiography / methods
Coronary Stenosis* / complications
Coronary Stenosis* / diagnosis
Coronary Stenosis* / physiopathology
Coronary Stenosis* / surgery
Coronary Vessels / pathology
Coronary Vessels / physiopathology
Coronary Vessels / surgery
Drug-Eluting Stents / adverse effects*
Echocardiography, Stress / methods
Humans
Male
Middle Aged
Monitoring, Physiologic / methods
Platelet Aggregation Inhibitors / therapeutic use
Sirolimus / analogs & derivatives*
Sirolimus / pharmacology
Treatment Outcome

Substances

Antibiotics, Antineoplastic
Platelet Aggregation Inhibitors
umirolimus
Sirolimus